Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents

Wolff, G; Bell, Michael; Escobar, James D; Ruiz, Stefani A

doi:10.1016/j.vaccine.2015.04.084

Cited by 6 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study showed that pertussis vaccination during childhood was effective in preventing pertussis in the household of confirmed cases, where pertussis transmission is high [9]. Several evaluative studies have found pertussis vaccination effectiveness ranging from 12 to 75% in preventing pertussis during outbreaks [10–12]. At present, however, no information is available regarding the association between pertussis costs and pertussis vaccination in infants and children.…”

Section: Introductionmentioning

confidence: 99%

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)

Plans-Rubió¹,

Navas²,

Godoy³

et al. 2018

PharmacoEconomics Open

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)

Plans-Rubió¹,

Navas²,

Godoy³

et al. 2018

PharmacoEconomics Open

View full text Add to dashboard Cite

show abstract

Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1–9 years old in Catalonia and Navarra (Spain)

Plans

Toledo

Sala³

et al. 2016

Eur J Clin Microbiol Infect Dis

View full text Add to dashboard Cite

Pertussis vaccination with 4-5 doses of acellular vaccines is recommended in Spain to all children at 2 months to 6 years of age. The effectiveness of the acellular pertussis vaccination was assessed in this study by comparing the incidence of secondary pertussis in vaccinated (4-5 doses) and unvaccinated or partially vaccinated (0-3 doses) household contacts 1-9 years old of confirmed cases of pertussis in Spain in 2012-13. Eighty-five percent of contacts had been vaccinated with 4-5 doses of acellular pertussis vaccines. During the 2-year study period, 64 cases of secondary pertussis were detected among 405 household contacts 1-9 years old: 47 among vaccinated and 17 among unvaccinated or partially vaccinated contacts. The effectiveness for preventing secondary pertussis, calculated as 1 minus the relative risk (RR) of secondary pertussis in vaccinated vs. unvaccinated/partially vaccinated contacts, was 50 % [95 % confidence interval (CI): 19-69 %, p < 0.01] when household contacts were vaccinated using DTaP, Tdap, hexavalent or heptavalent vaccines, and it was 51.3 % (95 % CI: 21-70 %, p < 0.01) when they were vaccinated using DTaP or TdaP vaccines. The effectiveness adjusted for age, sex, pertussis chemotherapy and type of household contact was 58.6 % (95 % CI: 17-79 %, p < 0.05) when contacts were vaccinated using available acellular vaccines, and it was 59.6 % (95 % CI: 18-80 %, p < 0.01) when they were vaccinated using DTaP vaccines. Acellular pertussis vaccination during childhood was effective for preventing secondary pertussis in household contacts 1-9 years old of pertussis cases in Catalonia and Navarra, Spain.

show abstract

Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand

Radke

Petousis‐Harris

Watson

et al. 2017

Vaccine

View full text Add to dashboard Cite

show abstract

Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents

Cited by 6 publications

References 23 publications

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)

Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1–9 years old in Catalonia and Navarra (Spain)

Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand

Contact Info

Product

Resources

About